Uganda launches Phase 1 trial for Bundibugyo Ebola strain vaccine
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
The town of Masaka in southern Uganda has launched a Phase 1 clinical trial for a vaccine candidate targeting the Bundibugyo strain of the Ebola virus. Currently, there are no approved treatments or vaccines available for this specific circulating strain.
Continue in the app — vote & join in ➔Source: France 24 (EN) · via ahirlevel.hu